These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3535197)

  • 21. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 22. A 21-day double-blind study of the effect of adding sustained-release theophylline (Nuelin SA) to inhaled salbutamol in patients with asthma.
    Sahay JN; Chatterjee SS
    Br J Dis Chest; 1983 Jan; 77(1):66-70. PubMed ID: 6344899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of a new once-a-day theophylline preparation with Theo-Dur given twice daily.
    Welch MJ; Kemp JP; Ostrom NK; Orgel HA; Meltzer EO; Romero L; Klinger N; McCarville S; Harrison LI
    J Asthma; 1993; 30(3):211-8. PubMed ID: 8325830
    [No Abstract]   [Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of theophylline in a slow-release 'sprinkle' format with a standard syrup preparation in young children with asthma.
    Dawson KP
    Pharmatherapeutica; 1986; 4(7):442-4. PubMed ID: 3960944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
    Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
    Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous treatment of asthmatic patients with enprofylline and theophylline.
    Laursen LC; Johannesson N; Weeke B
    Eur J Respir Dis; 1984 Oct; 65(7):504-8. PubMed ID: 6386511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled comparison of slow-release theophylline, ketotifen and placebo in the prophylaxis of asthma in young children.
    Carswell F; Stratton D; Hughes AO; Fysh WJ; Robinson P
    Agents Actions Suppl; 1983; 13():141-4. PubMed ID: 6346833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Theophylline--once or twice daily?].
    Schoch C; Menz G; Virchow C
    Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of children with sustained-release theophylline.
    Pedersen S; Nathan E
    Eur J Respir Dis; 1983 Nov; 64(8):564-70. PubMed ID: 6653683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Theophylline in allergic bronchial asthma (author's transl)].
    Kügler D; Wettengel R
    Prax Klin Pneumol; 1982 Jan; 36(1):27-32. PubMed ID: 7048279
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of 12-hour and 24-hour sustained-release theophylline in outpatient management of asthma.
    Tilles DS; Hales CA
    Chest; 1987 Mar; 91(3):370-5. PubMed ID: 3816315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.
    Berkowitz RB; Tinkelman DG; Marcoux JP; Rooklin AR; Zeitz HJ; Rennard SI; Moss BA; Hubbard RC; Lorber RR
    J Asthma; 1995; 32(4):275-84. PubMed ID: 7629003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.
    Beskow R; Ericsson CH; Grönneberg R; Sjögren I; Skedinger M
    Eur J Respir Dis; 1984 Oct; 65(7):509-11. PubMed ID: 6386512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.